M Bennish, A Eusof, B Kay, T Wierzba. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Ampicillin/pharmacologyAmpicillin/therapeutic useBangladeshDrug Combinations/pharmacologyDrug Combinations/therapeutic useDysentery, Bacillary/drug therapyDysentery, Bacillary/microbiologyHumansNalidixic Acid/pharmacologyNalidixic Acid/therapeutic usePenicillin ResistanceShigella dysenteriae/drug effectsSulfamethoxazole/pharmacologySulfamethoxazole/therapeutic useTrimethoprim/pharmacologyTrimethoprim/therapeutic useTrimethoprim, Sulfamethoxazole Drug Combination
Substances: See more » Drug CombinationsNalidixic AcidAmpicillinTrimethoprim, Sulfamethoxazole Drug CombinationTrimethoprimSulfamethoxazole
Year: 1985 PMID: 2863461 DOI: 10.1016/s0140-6736(85)92756-4
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321